Mar 15, 2016 - Therapeutic Innovation (CTI), which has established locations in New York ... CTI is an entrepreneurial n
Innovation Cluster 5 – Life Sciences 3:00pm – 5:00pm on Tuesday, March 15, 2016 Pfizer’s R&D Center at 610 Main Street, Cambridge MA 02139 The Pfizer R&D Center in Kendall Square, Cambridge, Massachusetts will host a Boston-area Life Sciences Innovator’s Panel and Q&A on Tuesday, March 15, 2016 from 3:00-5:00 PM. The Boston-area Life Sciences Innovator’s Panel and Q&A will feature a panel from Boston and Cambridge’s ecosystem of life science innovation, as well as innovation thought leaders. This event is orchestrated with the help of the Massachusetts life Sciences Center. Panelists will discuss how their organizations address innovation in the life sciences, as well as highlight the challenges they’ve faced as a life sciences innovator, success stories and unique opportunities for the future. Following the panel, a moderated question and answer session will allow conference attendees to pick our panelists brains. The event takes place March 15, 2016 from 3:00-5:00 PM in Pfizer’s R&D Center at 610 Main Street, Cambridge MA 02139. Please join us for thought-provoking presentations and a lively discussion. Pfizer R&D Center, Cambridge, Massachusetts Site Statistics •
280,000 square-foot, state-of-the-art R&D hub
• Opened in 2014, the facility brings together approximately 1,000 Pfizer employees who were previously spread out across three area locations • Located in the heart of Kendall Square, the unified Cambridge presence represents the opportunity to interlace Pfizer’s R&D capability with the densest biomedical community in the world • Pfizer Cambridge researchers are focused on translating scientific knowledge into potential medical breakthroughs across areas of unmet need such as lupus, inflammatory bowel disease, kidney disease, type 2 diabetes, muscular dystrophy and Parkinson's disease • The site’s new laboratory facilities, located at 610 and 700 Main Street, are leased from the Massachusetts Institute of Technology (MIT), continuing Pfizer’s tradition of working with MIT and other leading academic institutions to advance science, research and education
Functions: Pharmaceutical and Biotherapeutic/Biologics Research, Biotechnology Units, Development and Medical, Support Functions.
Drug
Metabolism,
Primary Therapeutic Areas: Inflammation and Immunoscience, Rare Diseases, Cardiovascular and Metabolic Diseases, and Neuroscience. Key Technologies: Biological Technologies (Large Molecule Technologies), Synthetic & Medicinal Chemistry, Genetics & Mathematical Modeling, ADME (absorption, distribution, metabolism, excretion and toxicity), Computational Sciences. In addition to the Pfizer’s Cambridge facilities, Massachusetts is home to Pfizer’s research and manufacturing site in Andover and is also the global headquarters for Pfizer’s Center for Therapeutic Innovation (CTI), which has established locations in New York City, San Diego and San Francisco. CTI is an entrepreneurial network of collaborations with leading academic medical centers.
Massachusetts Life Sciences Center Investing in the State of Innovation The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences.
Boston Area Life Sciences Innovation Cluster Driven by the cutting edge research activities at numerous Boston area universities, the Life Sciences Innovation Cluster is the most vibrant life sciences ecosystem in the United States. This Innovation Cluster is centered in the Kendall Square area of Cambridge, termed the most innovative square mile on the planet. Located here are numerous world class research facilities of pharmaceutical giants, highly successful biotechnology leaders, and almost uncountable emerging life sciences startups, many to be represented on our panel. This site visit and panel are orchestrated with the help of the Massachusetts Life Sciences Center and hosted by Pfizer at their Cambridge R&D Center in the heart of Kendall Square. Panel Moderator: Arpita Maiti, Director of External R&D, Pfizer Panelists: Pfizer – Peter Bergethon, M.D. -- Head of Computational Neuromedicine and Exploratory Human Biology, Pfizer MLSC – Travis McCready, President and CEO, Massachusetts Life Sciences Center Yumanity – Paulash Mohsen – Chief Business Officer, Yumanity Therapeutics IPI – Suzanne Grillo – Program Director Pediatric Drug Reformulation, Institute for Pediatric Innovation NSIV – Martha Farmer – President and CEO, North Shore InnoVentures This is an exclusive event for delegates to the ISPIM Innovation Forum Boston and select invited guests from MLSC and Pfizer.
For further details and to register for the ISPIM Boston Innovation Forum please visit: http://forum.ispim.org
